800-TEMPLE-MED Request Appointment
SEARCH TEMPLE HEALTH

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY) (ROCSTAR)

view all Clinical Trials

Overview

This study evaluates the effect of ROC-101 in adults with either Pulmonary Arterial Hypertension (PAH) or Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD-PH).

Clinical Trial Information

Protocol

TIRB# 32450

Phase

2

Condition(s)

Interstitial Lung Disease (ILD), Pulmonary Arterial Hypertension (PAH), Pulmonary Vascular Disease, Pulmonary Fibrosis (Including IPF)

Investigator

Parth Rali, MD

Coordinator

Susan Arleth, Kim Selwood, Aminah Davis

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Phase 2A, Open-Label Single Arm Multicenter Exploratory Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Doses of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH).